Health and Pharmaceuticals

P&G posts 34% fall in Q3 profit

Group to exit Duracell battery business after heavy writedown.

Colgate-Palmolive earnings fall in Q3

Group downgrades full-year earnings forecast as foreign exchange rates weigh.

ResMed lifts Q1 revenues

Manufacturer reaffirms commitment to top-line revenue growth as Q1 EPS tops forecasts.

Unilever posts fall in Q3 profit

by AFP
Dutch food and cosmetics giant hit by lower sales in China.

API posts $90m net loss in FY14

by AAP
Health and beauty products supplier confident of turning around earnings after series of writedowns.

GSK earnings beat expectations in Q3

Drugmaker unveils cost-cutting program as sales revenue lags.

Telstra targets healthcare with new deals

1 comment
Telco turns its health-services division into a stand-alone ‘Telstra Health’ unit; launches telemedicine joint venture with Swiss company Medgate.

Telstra pushes into healthcare

Telco make aggressive push into $120bn a year sector with new global and local partnerships.

Orion founder to retain key stake after IPO

The hospital software provider is looking to raise up to $NZ155m.

Orion Health confirms float details

by AAP
Global healthcare software solutions provider looking to raise up to $NZ150m through NZ, Aust floats.

Medibank IPO to raise up to $5.508bn

Prospectus shows Medibank shares priced in range between $1.55-$2 per share.

CSL enlisted in hunt for Ebola treatment

Australian firm acts on request from the Gates Foundation to develop plasma product in fight against Ebola.

Abbvie ditches Shire takeover

by AFP
US pharma giant U-turns on $54bn takeover after tax law tightens.

Choppy seas ahead for the Medibank float

6 comments
Volatility in the market may have increased, but analysts say there is still an appetite among investors for new listings.

Antara Lifesciences slumps on debut

by AAP
Biotech firm in hunt for diarrhoea cure loses 26% on ASX debut.

Ansell organic sales growth up 3% in Q1

Gloves and condom manufacturer reaffirms share earnings guidance, increases sales growth.

Medibank float gets strong pre-registration interest

Interest in health insurer’s $4 billion-plus IPO exceeds government expectations.

AbbVie wavers on Shire takeover

by AFP
US drugmaker reconsidering $US54 billion deal in light of US tax inversion crackdowns.

CSL announces $950m buyback

Global biotech manufacturer says it will buy back $950m of shares, holds FY profit guidance at 12%.

J+J earnings jump on higher sales

Third-quarter earnings lift 26 per cent despite stronger US dollar.

Pages